PMIII

PMIII (PF3D7_1408100), a food vacuole histo-aspartic protease, participates in hemoglobin degradation as one of several redundant proteases in the P. falciparum digestive vacuole (PMID:11782538, PMID:16731623). Despite substitution of a histidine for one of the two catalytic aspartate residues conserved in canonical aspartic proteases, PMIII is an active hydrolase and localizes to the food vacuole (PMID:11782538). It functions within an ~200-kDa multi-protein complex that co-purifies with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein, and is required for hemoglobin degradation and hemozoin formation (PMID:23471987). Individual gene disruption is tolerated, yielding viable parasites with normal morphology but slowed growth under amino acid limitation, reflecting functional redundancy among the food vacuole plasmepsins (PMID:15513918, PMID:16731623). PMIII copy number modulates piperaquine sensitivity: CRISPR-Cas9 knockout increases piperaquine sensitivity and slows hemoglobin digestion, yet protease inhibition, plasmepsin amplification, and amino acid limitation do not track with piperaquine susceptibility, implicating digestive vacuole pH homeostasis rather than proteolytic output per se (PMID:40720544); consistently, PMIII overexpression alone does not alter piperaquine, artesunate, or chloroquine sensitivity (PMID:30580023).

1. 2002 Medium

   Establishing that PMIII is a food-vacuole enzyme answered whether this histidine-substituted family member is catalytically active at all, showing it functions as a hydrolase despite lacking a canonical second catalytic aspartate.

   Evidence Genome-wide expression, food vacuole localization, and enzymatic activity assay in P. falciparum

   PMID:11782538

   Open questions at the time

   • Physiological substrate spectrum not defined beyond hemoglobin context
   • Catalytic mechanism of the His-for-Asp active site not structurally resolved
   • Individual contribution to hemoglobin degradation not measured
2. 2004 Medium

   Targeted disruption tested whether PMIII is individually essential, revealing dispensability with only a conditional growth defect and thereby exposing functional redundancy among food-vacuole plasmepsins.

   Evidence Double-crossover homologous recombination knockout and growth assays in rich versus amino acid-limited media in P. falciparum 3D7

   PMID:15513918

   Open questions at the time

   • Redundant partners not identified in this study
   • Mechanistic basis of the amino-acid-limited growth defect not dissected
3. 2006 Medium

   Combining plasmepsin inhibition with protease knockouts addressed whether PMIII is a viable single drug target, confirming overlapping proteolytic function makes the hemoglobin-degrading plasmepsins collectively poor single targets.

   Evidence Pepstatin A inhibition in falcipain-2/plasmepsin I/IV knockout lines with growth assays in amino acid-limited medium in P. falciparum

   PMID:16731623

   Open questions at the time

   • PMIII-specific contribution inferred from combinatorial rather than PMIII-directed manipulation
   • Relative catalytic weight of PMIII versus other proteases unquantified
4. 2013 Medium

   Biochemical purification answered how the food-vacuole hemoglobinases are organized, placing PMIII in an ~200-kDa complex with falcipain 2/2', plasmepsins II and IV, and heme detoxification protein required for hemoglobin degradation and hemozoin formation.

   Evidence Co-IP/MS, gel filtration co-elution, glycerol gradient cosedimentation, and in vitro interaction analyses in P. falciparum

   PMID:23471987

   Open questions at the time

   • Individual catalytic contribution of PMIII within the complex not dissected
   • Stoichiometry and architecture of the complex not resolved
   • Whether PMIII is required for complex assembly unknown
5. 2018 Medium

   Overexpression tested whether increased PMIII copy number alone drives antimalarial resistance, showing it is insufficient to alter piperaquine, artesunate, or chloroquine sensitivity.

   Evidence Transgenic PMIII overexpression in P. falciparum 3D7 with dose-response and piperaquine survival assays

   PMID:30580023

   Open questions at the time

   • Effect limited to two assay formats and a single genetic background
   • Does not test co-amplification with plasmepsin II
6. 2025 High

   Reciprocal CRISPR-Cas9 knockout and amplification separated proteolytic output from drug resistance, showing PMIII loss increases piperaquine sensitivity and slows hemoglobin digestion while implicating digestive vacuole pH homeostasis rather than increased proteolysis as the resistance mechanism.

   Evidence Single/double CRISPR-Cas9 knockouts, piperaquine sensitivity and hemoglobin digestion assays, protease inhibitor and amino-acid-limited culture, and digestive vacuole pH modulation in Cambodian P. falciparum

   PMID:40720544

   Open questions at the time

   • Direct causal link between PMIII and vacuolar pH not mechanistically defined
   • How PMIII copy number affects pH homeostasis unresolved

• The molecular basis by which PMIII activity or copy number influences digestive vacuole pH homeostasis, and how this couples to piperaquine sensitivity, remains unresolved.
• No mechanistic model linking PMIII to vacuolar pH regulation
• Structure of the His-for-Asp catalytic site and its substrate preference undefined
• PMIII's specific role within the ~200-kDa complex not isolated